RESEARCH TRIANGLE PARK, N.C., May 6 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics Holdings Corp. today announced that Lawrence D. Stern, chairman and chief executive officer of Talecris, will present at the Bank of America Merrill Lynch 2010 Health Care Conference at 2:20 p.m., Thursday, May 13, 2010, at The Grand Hyatt in New York, N.Y.
A live webcast of Talecris' presentation will be accessible through the investor relations section of the Talecris Web site, http://www.talecris.com/investor-relations.htm. A replay of the webcast will be available until May 28, 2010, and can be accessed at the same Web address.
About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.
Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: http://www.talecris.com/.
Talecris Biotherapeutics, Inc.
CONTACT: Drayton Virkler, +1-919-316-2356, Talecris Investor Relations,
drayton.virkler@talecris.com; Becky Levine, Talecris Corporate Communications,
+1-919-316-6590, becky.levine@talecris.com
Web Site: http://wwww.talecris.com/
